DHC members who are current employees of a pharmaceutical, biotech, or medical device companies are invited to take part in current anonymous surveys which will inform upcoming DHC research projects.
The role of the future marketer
The turmoil of 2020 has caused many pharma commercial organizations to reevaluate their go-to-market models and, in particular, the Role of the Marketer in the Future. The DHC Group has partnered with McKinsey & Company to develop a perspective that we will share beginning with an event hosted by BMS on Nov 18-19 (virtually) to better understand the evolution of the role of the marketer in the future. This survey will ask your opinions about recent changes related to the role of marketing.
Oncology Marketing Trends
This project examines the intersection of COVID-19/Diagnosis & Treatment/HCP-Patient interaction in the field of oncology. Inspired by recent research highlighting that oncology physicians/patients have seen a particularly significant shift in communication and treatment protocols in the face of COVID, this research will include quantitative physician and consumer studies. Additional insights will be pulled from qualitative responses from current or recent oncology pharmaceutical marketers.